Travere Therapeutics (TVTX) Return on Capital Employed Growth (5y) (2018 - 2026)
Travere Therapeutics (TVTX) Return on Capital Employed Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 5.37 Bn | 5.37 Bn | 125.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,218.00 |
| Dec 31, 2025 | 1,637.00 |
| Sep 30, 2025 | -806.00 |
| Jun 30, 2025 | -2,938.00 |
| Mar 31, 2025 | -3,650.00 |
| Dec 31, 2024 | -6,618.00 |
| Sep 30, 2024 | -8,476.00 |
| Jun 30, 2024 | -6,067.00 |
| Mar 31, 2024 | -6,058.00 |
| Dec 31, 2023 | -4,816.00 |
| Sep 30, 2023 | -4,108.00 |
| Jun 30, 2023 | -4,159.00 |
| Mar 31, 2023 | -4,399.00 |
| Dec 31, 2022 | -4,502.00 |
| Sep 30, 2022 | -3,791.00 |
| Jun 30, 2022 | -2,379.00 |
| Mar 31, 2022 | -1,818.00 |
| Dec 31, 2021 | -1,753.00 |
| Sep 30, 2021 | -2,365.00 |
| Jun 30, 2021 | -2,098.00 |